Label-Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer

Abstract EN

Breast cancer is the leading cause of cancer-associated death among women worldwide.

Its high mortality rate is related to resistance towards chemotherapies, which is one of the major challenges of breast cancer research.

In this study, we used label-free mass spectrometry- (MS-) based proteomics to investigate the differences between circulating proteins in the plasma of patients with chemoresponsive and chemoresistant luminal A breast cancer.

MS analysis revealed 205 differentially expressed proteins.

Furthermore, we used in silico tools to build protein-protein interaction networks.

Most of the upregulated proteins in the chemoresistant group were closely related and tightly linked.

The predominant networks were related to oxidative stress, the inflammatory response, and the complement cascade.

Through this analysis, we identified inflammation and oxidative stress as central processes of breast cancer chemoresistance.

Furthermore, we confirmed our hypothesis by evaluating oxidative stress and performing cytokine profiling in our cohort.

The connections among oxidative stress, inflammation, and the complement system described in our study seem to indicate a pivotal axis in breast cancer chemoresistance.

Hence, these findings will have significant clinical implications for improving therapies to bypass breast cancer chemoresistance in the future.